Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer

NCT05626309 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Esophagus Cancer

Interventions

DRUG: Qizhu Yuling Prescription
DRUG: Placebo

Sponsor

Jie Li